Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001210238-25-000005

Director sold 10,000 shares at an average $365.20 ($3,652,009)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BATE KENNETH Director 2025-08-15 Option exercise +10,000 $16.46 $164,600 12,627 D: show line 1 in the form
BATE KENNETH Director 2025-08-15 Sale −2,317 $363.41 $842,014 10,310 D: show line 2 in the form
BATE KENNETH Director 2025-08-15 Sale −2,516 $364.24 $916,428 7,794 D: show line 3 in the form
BATE KENNETH Director 2025-08-15 Sale −2,567 $365.33 $937,793 5,227 D: show line 4 in the form
BATE KENNETH Director 2025-08-15 Sale −600 $366.14 $219,683 4,627 D: show line 5 in the form
BATE KENNETH Director 2025-08-15 Sale −1,104 $367.63 $405,865 3,523 D: show line 6 in the form
BATE KENNETH Director 2025-08-15 Sale −896 $368.56 $330,226 2,627 D: show line 7 in the form
Open-market sales · 10,000 sh · avg $365.20 · $3,652,009

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BATE KENNETH Director 2025-08-15 Option exercise · Stock Option (Right to Buy) −10,000 0 D: show line 8 in the form
Loading xslF345X05/wk-form4_1755295493.xml…